Workforce Solutions

How to Build a Peptide Clinical Affairs Team From the Ground Up

How to Build a Peptide Clinical Affairs Team From the Ground Up
D
Dr. Michael Torres
|||12 min read
🔑Key Takeaway

  • Start hiring your first clinical affairs person 12 to 18 months before your IND filing date.
  • Your clinical affairs director should have at least 10 years of experience, ideally with peptide or biologic drugs.
  • Even when using a CRO, you need internal clinical oversight staff to manage the relationship effectively.
  • Budget for team growth in stages aligned to your pipeline, scaling from 1-2 people pre-IND to 15 or more in later phases.
  • Prioritize regulatory affairs specialists with peptide-specific experience since the pathway differs from small molecules.
  • Build diversity and training programs early to strengthen team retention and long-term clinical trial performance.

What Is a Clinical Affairs Team and Why Do You Need One?

A clinical affairs team manages everything related to clinical trials. They plan studies, submit regulatory filings, monitor trial sites, and make sure everything follows the rules.

For peptide companies, this team is the bridge between the lab and patients. Without them, your peptide never gets tested in humans.

Building this team from scratch can feel overwhelming. There are many roles to fill and regulations to follow.

But it does not have to be complicated. This guide breaks it down into clear steps.

Dr. Ken Getz, Deputy Director, Tufts Center for the Study of Drug Development, Clinical Trials Arena: "The biggest mistake small biotechs make is waiting until they have a candidate ready for the clinic before thinking about their clinical team. By then, you've already lost six months"

When to Start Building Your Clinical Affairs Team

Timing matters. Build too early and you waste money. Build too late and you delay your program.

Start hiring your first clinical affairs person when your lead peptide candidate is 12 to 18 months away from an IND (Investigational New Drug) filing.

At this point, you need someone who can plan the regulatory strategy and start preparing submissions.

As your pipeline grows, your team should grow with it. Here is a rough timeline:

Stage Team Size Key Hires
Pre-IND (12-18 months out) 1-2 people Clinical Affairs Director, Regulatory Specialist
IND Filing 3-5 people Add Clinical Operations Manager, Medical Monitor
Phase 1 Trial 5-8 people Add Clinical Research Associates, Data Manager
Phase 2/3 Trials 8-15+ people Add Biostatistician, Safety Officer, more CRAs

These numbers assume you are not outsourcing everything to a Contract Research Organization (CRO). If you use a CRO, you still need internal oversight, but with fewer people.

Peptide therapeutics have a higher clinical trial success rate than small molecules, with approximately 20% of peptide candidates reaching approval compared to roughly 10% for traditional drugs.

Core Roles in a Peptide Clinical Affairs Team

Let us walk through each key role and what they do.

Clinical Affairs Director

This person leads the team. They set the clinical strategy, manage budgets, and work closely with executive leadership.

They should have 10 or more years of experience in clinical development. Experience with peptide or biologic drugs is strongly preferred.

Regulatory Affairs Specialist

This person handles submissions to the FDA and other regulatory agencies. They prepare IND applications, annual reports, and responses to agency questions.

Look for someone with experience in the peptide or biologics space. The regulatory pathway for peptides can differ from small molecules.

Clinical Operations Manager

This person keeps trials running on time and on budget. They coordinate with CROs, trial sites, and vendors.

Strong project management skills are a must. Experience with peptide clinical trials is a plus but not always required.

Medical Monitor

A licensed physician who oversees patient safety during trials. They review adverse events and make medical judgments about trial protocols.

For peptide trials, look for a doctor with endocrinology, oncology, or immunology experience, depending on your therapeutic area.

Clinical Research Associates (CRAs)

CRAs visit trial sites to make sure everything is being done correctly. They check data, review records, and report issues.

You can hire CRAs directly or use a CRO. Many peptide companies use a mix of both.

Clinical Data Manager

This person designs case report forms, manages databases, and ensures data quality. Clean data is essential for regulatory submissions.

Biostatistician

Biostatisticians design the statistical analysis plan for your trials. They determine sample sizes, analyze results, and prepare reports for submissions.

The average cost of a Phase 3 clinical trial is between $12 million and $50 million. Having the right clinical affairs team can help you avoid costly delays and protocol amendments that drive those numbers even higher.

How to Hire Your First Clinical Affairs Director

Your first hire sets the tone for the entire team. Get this one right.

Where to look:

  • LinkedIn searches with keywords like "clinical affairs director" and "peptide" or "biologics"
  • Industry conferences like DIA (Drug Information Association) and AAPS
  • Referrals from your scientific advisory board
  • Specialized biotech recruiters

What to ask in interviews:

  • "Walk me through an IND submission you led from start to finish."
  • "How have you handled a clinical hold from the FDA?"
  • "Tell me about a time a trial site was underperforming. What did you do?"
  • "How do you build a clinical team for a company that has never run a trial before?"

Red flags to watch for:

  • Candidates who only talk about what their team did, never what they personally contributed
  • Lack of hands-on regulatory experience
  • No experience with peptide or biologic products
  • Poor communication skills

Rachel Kim, a biotech executive recruiter put it plainly: "Your first clinical affairs hire needs to be a builder, not just a manager. They should be comfortable rolling up their sleeves and doing the work while also planning for the team they will eventually lead"

Structuring Your Team for Efficiency

A flat team structure works best for small peptide companies. Everyone reports to the Clinical Affairs Director.

As you grow, you may need to add layers. But keep the hierarchy as simple as possible. Too many levels slow things down.

Here is a sample org chart for a mid-stage peptide company:

Clinical Affairs Director

  • Regulatory Affairs Specialist(s)
  • Clinical Operations Manager
    • Clinical Research Associates
    • Clinical Data Manager
  • Medical Monitor
  • Biostatistician

Communication is everything. Hold weekly team meetings and daily standups during critical trial phases.

Use project management tools like Monday, Asana, or Smartsheet to track milestones and deadlines.

Working with CROs

Most peptide companies do not run every aspect of their trials in-house. CROs handle much of the day-to-day work.

But you still need an internal team to oversee the CRO. This is called sponsor oversight, and regulators expect it.

When selecting a CRO, look for:

  • Experience with peptide or biologic trials
  • A track record in your therapeutic area
  • Transparent pricing and communication
  • References from other biotech sponsors

Your internal team should review CRO deliverables regularly. Do not assume everything is fine just because you are paying them.

Set clear expectations in the contract. Define timelines, quality standards, and escalation procedures.

Regulatory Considerations for Peptide Trials

Peptide drugs face unique regulatory challenges. Your clinical affairs team needs to understand them.

Key issues include:

  • Immunogenicity testing. Peptides can trigger immune responses. Your team needs to plan for immunogenicity assessments in clinical protocols.
  • Manufacturing consistency. The FDA looks closely at whether your peptide is made the same way every time. Clinical and CMC (Chemistry, Manufacturing, and Controls) teams must work together.
  • Stability data. Regulators want to see that your peptide product remains stable throughout the trial period.
  • Comparability studies. If you change your manufacturing process during development, you may need comparability studies.

The FDA's guidance on therapeutic peptide products provides detailed information on what regulators expect.

Before hiring your first clinical affairs director, ask candidates specifically about their experience navigating FDA feedback on peptide stability and immunogenicity data, as these are the two areas where peptide IND submissions most commonly stall.

Budget Planning for Your Clinical Affairs Team

Building a clinical affairs team is a significant investment. Plan your budget carefully.

Cost Category Annual Estimate
Clinical Affairs Director salary $180,000-$250,000
Regulatory Specialist salary $90,000-$130,000
Clinical Operations Manager salary $100,000-$140,000
CRA salaries (2 people) $140,000-$200,000
Medical Monitor (part-time consultant) $80,000-$150,000
Data Manager salary $85,000-$115,000
Biostatistician salary $110,000-$150,000
Tools and software $30,000-$60,000
Travel and site visits $50,000-$100,000
Total team cost $865,000-$1,295,000

These are rough numbers for US-based teams. Costs vary by location and experience level.

Remember, this investment is small compared to the cost of trial delays caused by an understaffed team.

Building a Diverse and Inclusive Team

Diverse teams make better decisions. This is especially true in clinical affairs, where understanding different patient populations is critical.

Make diversity a priority in your hiring process. Here is how:

  • Write job descriptions with inclusive language
  • Source candidates from a variety of channels, not just one network
  • Use structured interviews to reduce unconscious bias
  • Consider candidates from non-traditional backgrounds who bring relevant skills
  • Track diversity metrics and set goals

Clinical trials need to represent the patients who will use the drug. A diverse clinical affairs team is better equipped to design inclusive trials.

Training and Development

Once your team is in place, invest in their growth. The regulatory landscape changes constantly.

Encourage team members to:

  • Attend industry conferences (DIA, AAPS, ISPE)
  • Complete certifications like the RAC (Regulatory Affairs Certification)
  • Participate in FDA webinars and guidance document reviews
  • Join professional organizations

Create an internal knowledge-sharing program. When one team member learns something new, they should share it with the group.

Cross-training is also valuable. Having a regulatory specialist who understands clinical operations (and vice versa) makes your team more flexible.

For more on training strategies in peptide roles, read our guide on onboarding peptide manufacturing technicians.

Signs Your Clinical Affairs Team Needs to Grow

How do you know when it is time to add more people? Watch for these signs:

  • Regulatory submissions are consistently late
  • Team members are working overtime every week
  • Quality of work is slipping
  • CRO oversight is falling behind
  • New pipeline candidates are waiting for clinical support

Do not wait until your team is burned out. Start recruiting before you hit the breaking point.

A good rule of thumb: hire one additional clinical affairs professional for every two active clinical programs.

Common Pitfalls in Team Building

Avoid these mistakes:

  • Hiring all junior staff. You need experienced people to guide strategy, not just execute tasks.
  • Neglecting regulatory affairs. Some companies focus on operations and forget about regulatory submissions. Both are equally important.
  • Over-relying on CROs. Outsourcing is fine, but you still need internal expertise.
  • Ignoring team culture. Clinical trials are stressful. A supportive, collaborative culture helps the team push through tough times.
  • Failing to plan ahead. Build your team based on where your pipeline will be in 12 months, not where it is today.

For more on balancing internal and external hiring, check out our post on contract peptide chemist vs. full-time.

Start building your clinical affairs team 12 to 18 months before your IND filing and scale it in stages aligned to your pipeline, because internal clinical oversight is essential even when outsourcing to a CRO.

Frequently Asked Questions

How many people do I need on my clinical affairs team?

It depends on your pipeline. A company with one peptide in early clinical development might need 3 to 5 people. A company with multiple Phase 2 and Phase 3 programs could need 15 or more.

Should I hire a clinical affairs team or use a CRO?

Most peptide companies use both. You need an internal team for strategy and oversight, even if a CRO handles day-to-day trial operations.

What experience should a clinical affairs director have?

Look for at least 10 years of clinical development experience, with a track record in peptide, biologic, or small molecule programs. IND filing experience is essential.

How much does it cost to build a clinical affairs team?

A basic team of 5 to 7 people in the US will cost between $700,000 and $1.2 million per year in salaries alone. Add software, travel, and training for the full picture.

When should I start hiring for clinical affairs?

Begin 12 to 18 months before your planned IND filing. This gives your first hires enough time to develop the regulatory strategy and prepare submissions.

What is the most important quality in a clinical affairs team member?

Attention to detail. One mistake in a regulatory submission can delay your program by months. Hire people who are thorough and precise.

Final Thoughts

Building a peptide clinical affairs team is one of the most important investments you will make as a company. This team carries your science from the lab to the clinic.

Take the time to hire the right people. Structure the team for efficiency. Invest in training and growth.

The peptide companies that succeed in clinical development are the ones with strong, capable clinical affairs teams behind them. Start building yours today.

Topics

clinical affairs teampeptide clinical trialsbiotech team buildingclinical operations staffingregulatory affairs
MT

Dr. Michael Torres

Healthcare Staffing Consultant

MD, Healthcare Administration | 11 years in clinical staffing

Former physician turned healthcare staffing specialist. Advises peptide clinics and regenerative medicine practices on credentialing, provider placement, and team structure.

Reviewed by Dr. Michael Torres, MD, April 2026